Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits

Managed Care Interface

Volumn 20, Issue 6, 2007, Pages 26-30

  Bucaloiu, Ion D ^a   Akers, Gwendolyn ^a   Bermudez, Maria C ^a   Mainali, Roshan ^a   Brown, Barbara L ^a   Roberts, Stephanie S ^a   Hartle, James E ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; GOAL ATTAINMENT; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OUTPATIENT CARE; PHARMACIST; UNITED STATES;

AMBULATORY CARE; CLINICAL PROTOCOLS; ERYTHROPOIETIN; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MEDICAL AUDIT; OUTCOME ASSESSMENT (HEALTH CARE); PENNSYLVANIA; PHARMACISTS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 34447558376     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Levin A, Djurdjev O, Duncan J, et al: Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 2006;21:370-377.
2. Fink J, Blahut S, Reddy M, et al: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 2001;37:348-355.
3. Rossert J, Levin A, Roger SD, et al: Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 2006;47: 738-750.
4. 2004 Annual Data Report. United States Renal Data Systems (www.usrds.org/reference.htm), December 5, 2006.
5. Willey ML, Chagan L, Sisca TS, et al: A pharmacist-managed anticoagulation clinic: Six-year assessment of patient outcomes. Am J Health Syst Pharm 2003;60:1033-1037.
6. Chiquette E, Amato MG, Bussey HI: Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158:1641-1647.
7. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006;47(5 suppl 3):16-85.
8. Garcha J, Schwartz AB: Prevalence of iron deficiency in anemia of chronic kidney disease (CKD) stage 3 and 4 (abstract). Presented at the 2006 National Kidney Foundation 2006 Spring Clinical Meeting, Chicago, April 19-23.
9. Provenzano R, Bhaduri S, Singh AK: Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study. Clin Nephrol 2005;64:113-123.
10. Kulzer P, Schaefer RM, Krahn R, et al: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in nondialysis patients. European Multicentre Study Group. Int J Artif Organs 1994;17:195-202.
11. McClellan W, Aronoff SL, Bolton WK, et al: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004;20:1501-1510.
12. Portoles J, Torralbo A, Martin P, et al: Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1997;29:541-548.
13. Lefebvre P, Vekeman F, Sarokhan B, et al: Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin 2006; 22:1929-1937.
14. Lea J, Kewalramani R, Agodoa I, et al: Impact of anemia correction with an erythropoiesis stimulating protein (ESP) on renal function in chronic kidney disease (CKD) patients not on dialysis. Presented at the 2006 National Kidney Foundation 2006 Spring Clinical Meeting, Chicago, April 19-23.
15. Holdener KE, Price M, Becker BN, et al: Effect of anemia management on the progression of chronic kidney disease. Presented at the 2006 National Kidney Foundation 2006 Spring Clinical Meeting, Chicago, April 19-23.
16. Brimble KS, Rabbat CG, McKenna P, et al: Protocolized anemia management with erythropoietin in hemodialysis patients: A randomized controlled trial. J Am Soc Nephrol 2003;14:2654-2661.
17. Price M, Holdener, K, Becker BN, et al: Evaluation of an anemia management program in the pre-ESRD population. Presented at the 2006 National Kidney Foundation 2006 Spring Clinical Meeting, Chicago, April 19-23.
18. Hamilton R, Hawley S: Quality of life outcomes related to anemia management of patients with chronic renal failure. Clin Nurse Spec 2006;20:139-143.
19. Drueke T, Locatelli F, Clyne N, et al: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-2084.
20. Singh AK, Szczech L, Tang KL, et al: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098.